tirzepatide vs cagrisema Daniel J Drucker on X: "How will Cagri-Sema stack up against and later Retatrutide #obesity #weightloss #T2D https://t.co/ZPSQYq4RDo https://t.co/OtGQSvLysZ" / X CagriSema vs tirzepatide: which next-generation

Studies to clarify the riskbenefit ratio of DKA and improved cardio-renal outcomes with SGLT2i use in type 1 diabetes are required to help inform future guidelines and standardise clinical practice

Whether initiating GLP-1 RAs earlier - either concomitantly with surgery or immediately upon detecting early weight regain - could improve long-term outcomes remains to be investigated

Proven Track Record: Semaglutide has been used for several years, initially for managing type 2 diabetes and more recently for weight loss

This article breaks down every piece of safety data available, the known risks, what happens when you stop, and how to build a protocol that works for the long haul

While not a listed adverse reaction in the SmPC, persistent forceful vomiting can theoretically lead to Mallory-Weiss tearssmall lacerations in the oesophageal mucosa that may bleed